Found 26 matching trials
Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients PHASE2 The purpose of this study is to gather information on the safety and immuno...
Show More Location
Alabama Vaccine Research Clinic; University of Alabama at Birmingham
Learn More & Join Trial
A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects PHASE2 A randomized, double-blind, multicenter Phase II trial to compare the immun...
Show More Location
Miami Research Associates
Learn More & Join Trial
Combination Study With MVA BN and Dryvax PHASE1 The overall goals of this study are to expand the available data on the saf...
Show More Location
Saint Louis University
Learn More & Join Trial
A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants EARLY_PHASE1 The purpose of this study is to characterize the immune response in vivo us...
Show More Location
Clinical Pharmacology Unit
Learn More & Join Trial
A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects PHASE2 The primary objective of this study is to evaluate the immune response afte...
Show More Location
Harrison Clinical Research GmbH
Learn More & Join Trial
An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees PHASE2 The study was preformed to evaluate the persistence of antibodies following...
Show More Location
Harrison Clinical Research Deutschland GmbH
Learn More & Join Trial
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders PHASE1 The purpose of this study is to gather information on the safety and immuno...
Show More Location
Department of Infectious Diseases and Tropical Medicine
Learn More & Join Trial
High Dose IMVAMUNE® in Vaccinia-Naive Individuals PHASE2 The purpose of this research is to compare the ability of a new investigati...
Show More Location
University of Iowa - Vaccine Research and Education Unit
Learn More & Join Trial
Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally PHASE2 Due to recent concern of biowarfare and bioterrorism, the US government is ...
Show More Location
Emory Vaccine Center - The Hope Clinic
Learn More & Join Trial
Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients PHASE1 The purpose of this study is to gather information on the safety and immuno...
Show More Location
Indiana University School of Medicine
Learn More & Join Trial